Cargando…
Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions
Dendritic cells (DCs) are powerful activators of primary and secondary immune responses and have promising activity as anticancer vaccines. However, various populations of immune cells, including natural killer cells, regulatory T cells and especially cytotoxic T lymphocytes (CTLs), can inhibit DC f...
Autores principales: | Zhi-Iong Ma, Joel, Yang, Jianping, Qin, Jim S., Richter, Antonia, Perret, Rachel, El-Deiry, Wafik S., Finnberg, Niklas, ronchese, franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525606/ https://www.ncbi.nlm.nih.gov/pubmed/23264897 http://dx.doi.org/10.4161/onci.22128 |
Ejemplares similares
-
Murine CD4(+) T Cell Responses Are Inhibited by Cytotoxic T Cell-Mediated Killing of Dendritic Cells and Are Restored by Antigen Transfer
por: Ma, Joel Zhi-Iong, et al.
Publicado: (2012) -
Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy
por: Kuhn, Sabine, et al.
Publicado: (2015) -
Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013) -
P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting
por: Gokare, Prashanth, et al.
Publicado: (2017) -
Plasmacytoid Dendritic Cells Are Inefficient in Activation of Human Regulatory T Cells
por: Hubo, Mario, et al.
Publicado: (2012)